Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Experimental study of the eyelid reconstruction in situ with the acellular xenogeneic dermal matrix].

Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery·2007

Same author

[Mutation analysis of GCH1 gene in Chinese patients with dopa responsive dystonia].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·2007

Same author

[Screening and characterization of marine bacteria with antibacterial and cytotoxic activities, and existence of PKS I and NRPS genes in bioactive strains].

Wei sheng wu xue bao = Acta microbiologica Sinica·2007

Same author

[Collateral supply in patients with severe carotid stenosis].

Zhonghua yi xue za zhi·2007

Same author

[Changes of sleep architecture in patients with narcolepsy].

Zhonghua yi xue za zhi·2007

Same author

[Combined anterior and posterior approach for cervical fracture-dislocation with ankylosing spondylitis].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2007

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Thyroid Dysfunction Induced by Pembrolizumab: Five Case Reports.

Tingting Zhang¹, Jing Li^2,3, Junru Cai²

¹Department of Pharmacy, Heyuan People's Hospital, Heyuan, China.

Case Reports in Oncology

|July 14, 2026

Summary

Pembrolizumab can cause thyroid dysfunction, a common immune-related side effect. Early hormone replacement therapy improves thyroid function stabilization in patients receiving this cancer treatment.

Area of Science:

Immunology
Endocrinology
Oncology

Background:

Pembrolizumab, a programmed cell death receptor-1 (PD-1) inhibitor, has transformed cancer treatment but can cause immune-related adverse events (irAEs).

Keywords:

Immune checkpoint inhibitor Pembrolizumab Side effect Thyroid dysfunction

Related Experiment Videos

Last Updated: Jul 15, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Thyroid dysfunction is a frequent irAE, but its clinical course, management, and long-term effects require further characterization.